Sex-Selective Discrimination Common in Indian Wombs: US Study
By Hindustan Times,
Hindustan Times
| 03. 31. 2013
Indian women carrying male foetuses are likelier to receive pre-natal medical care than their counterparts pregnant with girls, a new research by American scientists suggests, raising fresh, uncomfortable questions about the discrimination against girls that starts in the womb.
The scientists, who studied 30,000 Indian women captured in the National Family Health Survey, found that those pregnant with boys were more likely to go to pre-natal medical appointments, take iron supplements, deliver babies in healthcare facilities and receive tetanus shots.
“It paints a pretty dire picture of what’s happening,” said Leah Lakdawala, an assistant professor of economics at Michigan State University.
The research by Lakdawala and Prashant Bhardwaj of the University of California San Diego is published in the latest issue of the reputed Journal of Human Resources.
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...